ASH President: Immigration Decision Disappointing

Published on: June 27, 2018

(WASHINGTON, June 27, 2018) — Yesterday, the Supreme
Court of the United States upheld President Trump’s authority to restrict
immigration from seven countries. The American Society of Hematology (ASH) has
opposed every iteration of this policy1,
2
and previously joined the Association of American Medical Colleges and 33 other
health care organizations in filing an amicus brief urging the Court to
reinstate a nationwide injunction against it.

ASH President Alexis A. Thompson, MD, MPH, of the Ann
and Robert H. Lurie Children’s Hospital of Chicago, responded to the Court’s
ruling:

“Yesterday’s
ruling by the Supreme Court is disappointing. Every year, talented medical
professionals come to the United States to learn, collaborate, and advance the
fields of science, health, and medicine. ASH recognizes the contributions of
all scientists and caregivers, regardless of national origin, and will work
with lawmakers on Capitol Hill to find legislative solutions that keep our
borders strong while ensuring the United States attracts the strongest possible
biomedical research workforce from around the globe.”

The American Society of Hematology
(ASH) (www.hematology.org) is the
world’s largest professional society of hematologists dedicated to furthering
the understanding, diagnosis, treatment, and prevention of disorders affecting
the blood. For more than 50 years, the Society has led the development of
hematology as a discipline by promoting research, patient care, education,
training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org),
the most cited peer-reviewed publication in the field, which is available
weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an
online, peer-reviewed open-access journal.